Background: The knowledge level of atrial fibrillation patients about their arrhythmia, its consequences and treatment is poor. The best strategy to provide education is unknown. Aim: To investigate the effect of reinforced targeted in-person education using the Jessa Atrial fibrillation Knowledge Questionnaire (JAKQ). Methods: Sixty-seven atrial fibrillation patients were randomized to standard care (including brochures) or targeted education. Follow-up visits were scheduled after one, three, six and 12 months. Targeted education during each visit focused on the knowledge gaps revealed by the JAKQ. Patients completed two questionnaires to assess their quality of life and symptom profile. Adherence to non-vitamin K antagonist oral anticoagulants was measured using electronic monitoring. Results: Sixty-two patients (31 education; 31 standard care) completed follow-up. Median baseline score on the JAKQ was similar in education (62.5%) and standard care group (56.3%; p=0.815). The intervention group scored significantly better over time (one month: 75.0%, 12 months: 87.5%; p<0.001) whereas there was no significant improvement in the control group (one month: 62.5%, 12 months: 62.5%; p=0.085). Providing targeted education after completion of the JAKQ required on average 6.9±4.6 min. Some improvements in quality of life, symptom burden and adherence were shown, without significant differences between the two groups (p-values between 0.282 and 0.677).
Introduction
Atrial fibrillation is putting a large burden on the healthcare system and its prevalence is further increasing. 1 Optimal care of atrial fibrillation patients includes a proper understanding by the patient about the arrhythmia, its treatment and its management. 2, 3 The 2016 European Guidelines on the management of atrial fibrillation indicate that a more integrated patient education is warranted. 2 Better patient knowledge can contribute to enhanced selfmanagement and shared decision making. 2 Nevertheless, education is not systematically provided during the current care of atrial fibrillation patients and is likely suboptimal to achieve proper patient knowledge. 4, 5 Different studies showed that the knowledge and insight of atrial fibrillation patients about their arrhythmia and its management are poor even after receiving verbal and/or written information. [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] Various educational interventions that were previously tested led only to mixed results and a feasible and effective manner of providing education is difficult to establish. [8] [9] [10] [15] [16] [17] [18] A consensus paper of the European Heart Rhythm Association stated that education should be provided in a standardized, structured and tailored way. 3 Validated questionnaires can be helpful in this respect as a way to map knowledge deficits and to target education specifically to the needs of every patient but such a strategy has never been evaluated in daily practice. 3 Therefore, the main aim of this study was to investigate the effect of reinforced, targeted, in-person education of atrial fibrillation patients on their knowledge level. Enhancing disease-related knowledge is an important part of an integrated approach to optimize overall care and to improve other clinical outcome parameters in patients with chronic conditions, such as atrial fibrillation. 15, 16, [19] [20] [21] This has previously been demonstrated in, for example, heart failure patients. 22, 23 Therefore, a possible influence on quality of life (QOL), symptom burden and medication adherence was additionally explored in this study.
Methods

Design and study population
A prospective randomized controlled study was performed at a large Belgian tertiary care hospital between January 2016 and April 2017. Patients with atrial fibrillation hospitalized at the cardiology ward or seen at the out-patient clinic were recruited for this study. Patients were excluded if they were younger than 18 years, not capable of signing the informed consent, unable to speak Dutch or when they were cognitive-impaired. A chart review was performed to evaluate demographic variables and the medical history of every patient. The study complied with the Declaration of Helsinki. Ethical approval was obtained from the local ethical committee and all patients provided written informed consent.
Study procedure and targeted education
After inclusion at baseline, all atrial fibrillation patients were requested to come to the hospital for a study visit (i.e. data collection for the control group and additional education for the intervention group) at fixed time points: after one, three, six and 12 months (Figure 1 ). In the event that a patient was too ill or not able to come to the hospital for a follow-up visit, this in-person visit was replaced by a telephone follow-up. Patients had to complete three questionnaires during each visit to assess their QOL, symptom burden and knowledge level about atrial fibrillation and oral anticoagulation (OAC) therapy. From the first until the third month, patients' adherence to their non-vitamin K antagonist oral anticoagulant (NOAC) was measured, if possible (i.e. only adherence to apixaban and rivaroxaban could be monitored). Details about the questionnaires and adherence measurements are described below.
Patients were randomly assigned in a 1:1 allocation to an education group (intervention group) or a standard care group (control group). Patients were allocated based on a computer-generated number randomization list with block sizes of four, six and eight prepared by a researcher who was not clinically involved. Stratification occurred based Figure 1 . Study design. The dark green striped vertical bars indicate the moments when each AF patient received targeted education based on specific knowledge gaps of that patient. The light blue period represents the two months of adherence measurement (only adherence to apixaban and rivaroxaban could be monitored).
on age, highest educational degree and time since the diagnosis of atrial fibrillation. In the intervention group, on top of standard care, the study team, consisting of two allied health professionals (LD, LE), reinforced education based on the incorrectly answered questions of the Jessa Atrial fibrillation Knowledge Questionnaire (JAKQ; Supplementary Material Table 1 online) . 12 More specifically, after completion of the JAKQ, the study team went through the questionnaire together with the patient and indicated for each question whether the answer was correct or not. If the answer was correct, the study team immediately moved on to the next question. If the answer was wrong, the correct answer was indicated and shortly explained. No additional educational materials were used. To assure consistency between the two allied health professionals in delivering the intervention, the following training was provided by the electrophysiology team before the start of the trial: i) literature study, ii) attending out-patient visits (on a regular basis for four weeks) at which an experienced electrophysiologist provided general atrial fibrillation education, iii) during the following four weeks the study members regularly provided patient education themselves (by means of the JAKQ) under supervision of an electrophysiologist. In the control group, patients received standard care with no extra focused reinforcements and knowledge evolution was only monitored. Standard care in our hospital includes information from the cardiologist during outpatient visits or hospitalizations, and an information booklet about atrial fibrillation and OAC therapy (Supplementary Appendix 1 online), which was provided at the first visit.
Measured parameters
Together with the atrial fibrillation knowledge assessment (using the JAKQ), other parameters such as symptom burden (using the Leuven ARrhythmia Questionnaire (LARQ)), QOL (using the 12-Item Short Form Health Survey (SF-12) questionnaire) and adherence to NOACs were evaluated. Time to complete the JAKQ and to provide 12 Patients without OAC indication had to complete only the first eight questions of the JAKQ. In patients who completed both eight and 16 questions during the trial -because they had to start or stop OAC -only the first eight questions were taken into account for data analyses. The JAKQ contains only multiple choice questions with one correct answer, two distracters and one 'I do not know' option. A correct answer was scored as one point; incorrect and 'I do not know' answers as zero points. The total score on the JAKQ was divided by the number of completed questions, resulting in a percentage.
QOL. The SF-12v2 consists of 12 questions to evaluate eight health and well-being concepts including physical functioning, role limitations due to physical health problems, bodily pain, general health, vitality, social functioning, role limitations due to emotional problems and mental health. 25, 26 Additionally, the physical component summary (PCS) and mental component summary (MCS) score were calculated. For each item, the weighted sum of the questions was calculated and transformed in a 0-100 scale. The higher the score, the better the QOL. The recall period was four weeks. The SF-12v2 was previously evaluated in the US National Health and Wellness Survey in atrial fibrillation patients 27 and the questionnaire was able to show an impact of atrial fibrillation-related interventions such as a pulmonary vein isolation 28 and a percutaneous closure of the left atrial appendage. 29 Symptom burden. The LARQ is based on the six most important atrial fibrillation-related symptoms: palpitations, shortness of breath, chest pain, syncope, dizziness and fatigue. 30 The LARQ was previously validated based on content, face, construct (known-groups and convergent) validity and internal consistency reliability (Cronbach's α 0.909-0.952). 30 For each of these symptoms (except syncope), symptom prevalence, occurrence (frequency, duration, severity), distress, circumstances triggering the symptom, and effect on daily activities were requested. Questions were based on a recall period of four weeks. By means of specific algorithms, subscale scores on five domains (symptom frequency, duration, effect on daily activities, severity and distress) were calculated by summing the raw scores and transforming them to a 0-100 scale. Higher scores represent a more pronounced symptom burden.
Adherence. Adherence to NOACs was measured in atrial fibrillation patients taking apixaban (twice daily NOAC) and rivaroxaban (once daily NOAC) by means of electronic monitoring. Adherence to apixaban was measured with the 'Helping Hand' device (WestRock, Switzerland). This device, in the form of a blister sleeve, measures the exact date and time whenever a patient removes the blister from the device to take his/her medication. Adherence to rivaroxaban was measured with the medication event monitoring system (WestRock, Switzerland), which is a special cap that fits onto a medication bottle to record the exact date and time of bottle openings. Devices without a display were used. Dabigatran adherence could not be measured with the monitoring devices, as this drug should be stored in the original package to protect it from moisture and the blister does not fit into the Helping Hand. Edoxaban was not yet approved for use at the time of study initiation. Taking adherence (proportion of prescribed doses taken), regimen adherence (proportion of days with the correct number of doses taken) and number of unprotected days (⩾3 or ⩾1 consecutively missed doses for apixaban or rivaroxaban, respectively, or excess doses during the prior 24 h) were calculated based on the retrieved data, assuming that every bottle opening or blister removal represents a medication intake. 31 Pill counts were performed during the three month follow-up visit.
Statistical analysis
According to the power calculation (power of 80%; alpha of 5%), at least 56 atrial fibrillation patients (28 in each study group) had to be included to achieve a 25% increase in the primary outcome of knowledge level after one year compared with baseline. 12 This estimated effect size was based on previous pilot data showing a 29.4% increase after a few days and a 24.9% increase after one month. 12 An additional drop-out margin of 15% was taken into account, resulting in a minimal inclusion rate of 66 patients. The study was not powered for the secondary outcome measures. Statistical analyses were performed using SPSS 25.0 (IBM, Armonk, USA 
Results
Patient characteristics
Of the 129 atrial fibrillation patients asked to participate, 62 patients (36 hospitalized and 26 outpatients) were excluded as they did not want to participate (37%) or were too ill (29%) (Figure 2 ). Of the 67 included patients (26 hospitalized and 41 out-patients), 33 were randomized to the intervention group and 34 to the control group. There was a dropout rate of 7.5% and 31 patients in each group completed all follow-up visits. Eventually, 94.4% of the follow-up visits occurred in person and 5.6% (4.0% in the control and 1.6% in the intervention group) by telephone follow-up. The included atrial fibrillation population was 72.1±8.6 years old and most patients (73.1%) had received the atrial fibrillation diagnosis more than one year before study initiation. Patients randomized to the control group and the education group were well matched on different demographic characteristics (Table 1) . improved the knowledge level (p=0.001 between baseline and one month). Additional education sessions further increased and maintained this knowledge level (p=0.080 between one and 12 months). The knowledge score over time was significantly different between the two groups (p=0.0006). Targeted education improved the knowledge level for all different atrial fibrillation aspects. At the end of the study, significantly more patients in the education group knew that atrial fibrillation can be asymptomatic compared with baseline (74.2% vs. 25.8%; p<0.001). At the start, only 41.9% of all patients indicated that one can detect atrial fibrillation by regularly taking his pulse; this was 74.2% after reinforced education (p=0.010). At the start, only one in four patients (25.8%) knew that atrial fibrillation will increasingly recur with ageing, despite medication; this was 64.5% after 12 months (p=0.002). Furthermore, at 12 months 96.3% of the patients on OAC versus only 63.0% at baseline were aware of the possible bleeding complications associated with the therapy (p=0.002). Finally, 77.8% of the patients taking VKA or NOAC knew what to do when missing a dose; this was only 25.9% at the start of the study (p<0.001). Figure 1) . The PCS did not change significantly over time in either group (control: p=0.873; education: p=0.077). The MCS did not change significantly over time in the control group (p=0.094), but there was a significant increase in the MCS score between baseline and three months (p=0.008) and one month and three months (p=0.026) in the in-person education group. The PCS and MCS scores over time were, however, not significantly different between the two groups (p=0.462 and p=0.677 respectively).
Effect on knowledge level
Impact on QOL
Effect on symptom burden
The overall symptom burden on the LARQ was the highest at baseline and decreased over time (standard care: p=0.007, education: p=0.239; Supplementary Figure 2) . However, the overall symptom burden score over time was not significantly different between the two groups (p=0.669). A detailed representation of the symptom experience per symptom and per burden domain during the different follow-up visits is shown in Supplementary Figure 3 .
Impact on adherence
Adherence to NOACs was measured in 29 patients: 14 in the control group (10 rivaroxaban, four apixaban) and 15 in the education group (10 rivaroxaban, five apixaban). Taking adherence (p=0.464), regimen adherence (p=0.619) and pill count (p=0.282) were numerically higher in the education group, but not significantly so due to the small groups and large variability in adherence measures (Supplementary Figure 4) . The number of unprotected days was also not statistically lower in the intervention group (p=0.417).
Discussion
Patients' knowledge about atrial fibrillation and OAC therapy is of pivotal importance for their overall management. However, this aspect is often overlooked and not systematically addressed due to time constraints of physicians and the lack of proven efficient educational interventions. 3, 5 
Patient knowledge regarding atrial fibrillation
The score on the JAKQ (58.5%) at baseline in both study groups was comparable to two previous large population surveys with the JAKQ (55.8-61.6%). 12, 14 This indicates that a representative subset of patients was included in this study, despite the fact that almost half of the patients were not willing or not able to participate. Although standard care consisted of an information brochure in addition to information from the cardiologist, very important knowledge gaps were still present. The standard care in our study was probably better than the average daily care in most centres since a European survey showed that only 22.7% of cardiology centres make use of a patient information brochure. 32 Notwithstanding, 43.4% of the centres indicated they had a structured programme for patient education. 32 The lack of knowledge by patients concerned various aspects of atrial fibrillation care and OAC therapy, as previously also shown by other studies making use of (validated) questionnaires. [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] Educational strategies for atrial fibrillation Our study shows that the JAKQ is a good instrument to guide education in a more individualized and targeted manner. After one targeted in-person education session, the knowledge level had significantly improved. Additional education sessions at one and three months further increased the knowledge level and this improved level was maintained during the following visits due to repeated reinforced education, stressing the importance of the repetitive character of such intervention. It was somewhat surprising to note that providing the JAKQ to the control group during each visit did not improve their scoring over time. Although we have not systematically evaluated this aspect, it seems that the JAKQ by itself did little to trigger those patients to fill the gaps in their knowledge by consulting the brochures that were provided to them, by asking healthcare workers or by actively searching online resources.
Various other educational methods, frequently focusing on OAC therapy, have been evaluated in atrial fibrillation patients, with mixed results: brochures, [8] [9] [10] 15 educational videos, 9,10 group education sessions, 9 general face-toface education, 15,16 a complex general practice driven programme 17 and a mobile application. 18 An intervention in which an information booklet was given to and discussed with the patient had no significant impact on the awareness about atrial fibrillation and the potential side effects and benefits of OAC therapy. 8 McCabe et al. evaluated the effect of education by nurses in hospitalized patients with recently detected atrial fibrillation using atrial fibrillation and OAC brochures together with a video about OAC therapy: two weeks after the hospitalization, knowledge was not retained. 10 Hendriks et al. showed that a nurse-led atrial fibrillation chronic care programme including reinforced in-person education at regular time points can lead to a significant increase (14.1%) in atrial fibrillation-related knowledge after one year. 16 This education was more comprehensive, including general information about atrial fibrillation, treatment options and lifestyle interventions combined with psychosocial support. 6, 16 The educational visits in that study took 30 minutes of time, which of course impacts personnel costs. In Hendriks' study, the knowledge level of the control group also significantly improved, by 10.8%, which was not the case in our study.
Feasibility of reinforced targeted education based on the JAKQ
The JAKQ has proven to be a fast and valid tool to assess existing knowledge of atrial fibrillation patients in about 6-7 min. Moreover, by targeting the education to only the knowledge deficits of the patient, limited time of an allied health professional (i.e. up to 8.5 min) was needed during each visit. Only a short training period of the healthcare providers is required to implement this method of education as the JAKQ provides guidance. Targeted education based on the JAKQ is therefore feasible for use in daily care from the perspective of both the hospital and the patient. All patients will receive education in a uniform way without being overwhelmed by too much or superfluous information and by only focusing on the important key aspects in their management. By implementing the JAKQ in a tablet application, as performed in this study, patients are able to complete it at home or in the waiting room before their visit. During the visit, a healthcare practitioner can then provide immediate targeted education. This way, providing targeted education was implemented as an integral piece of the entire care framework of a specialized atrial fibrillation clinic. 33, 34 Impact of education in atrial fibrillation patients So far only a few studies have investigated the effect of an educational strategy on clinical outcome parameters. Although our study was not powered for these secondary outcome parameters, some statistically significant differences were found in QOL and symptom burden. Emotional health was lowest and symptom burden highest at baseline in both groups. It is difficult, however, to draw definitive conclusions about the effect size of the education intervention itself on improvements in QOL and symptom burden. For example, 38.8% of the participants were included during an (un)planned hospitalization, which is a state of high symptom burden, which tends to regress towards a more stable out-patient setting. The contribution of education to improved patient coping with atrial fibrillation-related symptoms remains to be determined. In any case, education seems to be an important driver of improved QOL. The nurse-led integrated chronic care programme of Hendriks et al. that included patient education as an important pillar also showed that the QOL (measured with the SF-36 questionnaire) significantly improved over time in both the intervention group and the standard care group. 16 This also led to a decrease in anxiety over time in both study groups. 16 Optimal adherence to OAC medication, especially with NOACs, is of great importance to achieve the prognostic benefit of anticoagulation. Therefore, half of the JAKQ questions are attributed to OAC. A systematic review from 2017, however, did not find any effect of educational and behavioral interventions on time in therapeutic range in atrial fibrillation patients taking VKA. 35 Three large trials investigated the effect of an educational intervention on NOAC adherence. 21, 36, 37 Although the AEGEAN trial did not show any impact of a structured educational programme (i.e. booklet, reminder tools and follow-up telephone calls) on adherence to apixaban, 36 the IMPACT-AF trial (majority of patients still on VKA) showed that an educational intervention for both patients and healthcare providers improved OAC use in atrial fibrillation patients. 21 The FACILITA study showed that a mixed intervention, consisting of patient education and a simple calendar reminder, led to a dabigatran regimen adherence of 89.2% compared with 63.2% in a control group after one year. 37 In our study the effect of targeted education was evaluated on NOAC adherence measured with electronic monitoring, showing lower values in the standard care group but not significantly different from the education group, possibly due to the small sample size and the short monitoring period. Electronic adherence monitoring can also be used as a tool to promote a good adherence by discussing the measured data together with the patient or even by providing direct feedback based on telemonitoring, as part of an educational programme. 38 
Study limitations
This is a single centre study with a small sample size, although it was correctly sized for the primary outcome. Almost half of the eligible patients did not participate. Beyond a study setting this probably would have been lower, that is, the possibility to be randomized to a control group could have had an impact and in daily practice education sessions can be coupled to planned hospital visits. Generalizability of these results to other settings should be made with caution as the impact of this intervention can depend on the experience and enthusiasm of the healthcare workers providing the education. In our hospital no standardized educational programme for atrial fibrillation patients is yet implemented beyond regular physician contacts and provision of information brochures. Although electronic monitoring is assumed to be one of the most accurate ways to measure adherence, it is always possible that patients do not use the device correctly for a certain period or do not take their medication although a device registration occurred. 39 However, it is already seen that using such devices can lead to increased patient motivation to take their medications better than usual. 38 
Future perspectives
A large, randomized, controlled, multicentre trial could be set up to evaluate the impact of targeted in-person education as part of daily care on different clinical outcome data (e.g. complications, hospitalizations, emergency room visits) and on other secondary outcome measures for which this trial was not powered. Fuenzalida et al. recently showed that nurse-led education at discharge from the emergency department significantly decreased atrial fibrillationrelated complications, treatment-related complications, and death. 15 Further, the cost-effectiveness of such interventions should be evaluated. We have currently started such a large-scale prospective trial, including integral targeted patient education, funded through the Flemish government. It demonstrates the interest of health authorities in finding ways to optimize implementation of guideline-based care through enhanced patient involvement.
Conclusion
The JAKQ is a suitable tool to provide individualized education for atrial fibrillation patients. A first, targeted, in-person educational session based on the JAKQ significantly improved patients' knowledge level. Additional educational sessions maintained and strengthened this effect. This study showed some improvements on QOL, symptom burden and likely medication adherence, although not significantly different between the two groups. Integrated targeted education opens the perspective for improving clinical outcomes and prognosis of atrial fibrillation patients.
Implications for practice
• • The best strategy to provide education for atrial fibrillation patients is unknown.
• • The Jessa Atrial fibrillation Knowledge
Questionnaire proved to be an effective tool to provide individualized education. • • Reinforced, targeted, in-person education is feasible to implement in daily practice.
